Tower Research Capital (TRC)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,771
Closed -$938K 6927
2022
Q3
$938K Sell
13,771
-1,211
-8% -$82.5K 0.02% 731
2022
Q2
$479K Buy
14,982
+7,123
+91% +$228K 0.01% 1164
2022
Q1
$273K Buy
7,859
+562
+8% +$19.5K ﹤0.01% 1524
2021
Q4
$213K Sell
7,297
-1,364
-16% -$39.8K ﹤0.01% 1727
2021
Q3
$221K Buy
8,661
+6,092
+237% +$155K 0.01% 1724
2021
Q2
$90K Buy
2,569
+1,842
+253% +$64.5K ﹤0.01% 2517
2021
Q1
$30K Sell
727
-12,092
-94% -$499K ﹤0.01% 3577
2020
Q4
$555K Buy
12,819
+10,606
+479% +$459K 0.02% 912
2020
Q3
$122K Sell
2,213
-13,064
-86% -$720K ﹤0.01% 2991
2020
Q2
$964K Buy
+15,277
New +$964K 0.04% 550
2020
Q1
Sell
-4,888
Closed -$389K 4223
2019
Q4
$389K Buy
4,888
+2,713
+125% +$216K 0.03% 358
2019
Q3
$106K Sell
2,175
-1,265
-37% -$61.7K 0.01% 1318
2019
Q2
$181K Buy
3,440
+3,338
+3,273% +$176K 0.01% 892
2019
Q1
$5K Sell
102
-758
-88% -$37.2K ﹤0.01% 3115
2018
Q4
$35K Sell
860
-763
-47% -$31.1K ﹤0.01% 1542
2018
Q3
$62K Buy
1,623
+437
+37% +$16.7K ﹤0.01% 1632
2018
Q2
$54K Sell
1,186
-281
-19% -$12.8K ﹤0.01% 1815
2018
Q1
$71K Buy
1,467
+445
+44% +$21.5K 0.01% 1477
2017
Q4
$40K Buy
1,022
+955
+1,425% +$37.4K 0.01% 1510
2017
Q3
$2K Sell
67
-774
-92% -$23.1K ﹤0.01% 3611
2017
Q2
$23K Buy
+841
New +$23K ﹤0.01% 1153
2017
Q1
Sell
-200
Closed -$3K 4179
2016
Q4
$3K Buy
+200
New +$3K ﹤0.01% 3317
2016
Q3
Sell
-1,331
Closed -$22K 4724
2016
Q2
$22K Buy
1,331
+189
+17% +$3.12K ﹤0.01% 2174
2016
Q1
$18K Buy
1,142
+1,077
+1,657% +$17K ﹤0.01% 1451
2015
Q4
$2K Sell
65
-2,265
-97% -$69.7K ﹤0.01% 3860
2015
Q3
$99K Buy
+2,330
New +$99K 0.01% 579